Gearry RB - Search Results

1

Review article: Measuring disease severity in inflammatory bowel disease - Beyond treat to target.

Swaminathan A, Day AS, Sparrow MP, Peyrin-Biroulet L, Siegel CA, Gearry RB. Swaminathan A, et al. Among authors: gearry rb. Aliment Pharmacol Ther. 2024 Nov;60(9):1176-1199. doi: 10.1111/apt.18231. Aliment Pharmacol Ther. 2024. PMID: 39403053 Review.

2

Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.

Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA, Roberts RL, Kennedy MA. Gearry RB, et al. Aliment Pharmacol Ther. 2003 Aug 15;18(4):395-400. doi: 10.1046/j.1365-2036.2003.01690.x. Aliment Pharmacol Ther. 2003. PMID: 12940924 Clinical Trial.

3

Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease.

Priest VL, Begg EJ, Gardiner SJ, Frampton CM, Gearry RB, Barclay ML, Clark DW, Hansen P. Priest VL, et al. Among authors: gearry rb. Pharmacoeconomics. 2006;24(8):767-81. doi: 10.2165/00019053-200624080-00004. Pharmacoeconomics. 2006. PMID: 16898847

4

Review article: appropriate use of corticosteroids in Crohn's disease.

Irving PM, Gearry RB, Sparrow MP, Gibson PR. Irving PM, et al. Among authors: gearry rb. Aliment Pharmacol Ther. 2007 Aug 1;26(3):313-29. doi: 10.1111/j.1365-2036.2007.03379.x. Aliment Pharmacol Ther. 2007. PMID: 17635367 Review.

5

Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy?

Newnham E, Hawkes E, Surender A, James SL, Gearry R, Gibson PR. Newnham E, et al. Aliment Pharmacol Ther. 2007 Oct 1;26(7):1019-24. doi: 10.1111/j.1365-2036.2007.03449.x. Aliment Pharmacol Ther. 2007. PMID: 17877508

6

IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.

Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, Timms KM, Gutin A, Lanchbury JS, Merriman TR, Barclay ML, Kennedy MA. Roberts RL, et al. Among authors: gearry rb. Am J Gastroenterol. 2007 Dec;102(12):2754-61. doi: 10.1111/j.1572-0241.2007.01525.x. Epub 2007 Sep 25. Am J Gastroenterol. 2007. PMID: 17894849

7

Review of fecal biomarkers in inflammatory bowel disease.

Sutherland AD, Gearry RB, Frizelle FA. Sutherland AD, et al. Among authors: gearry rb. Dis Colon Rectum. 2008 Aug;51(8):1283-91. doi: 10.1007/s10350-008-9310-8. Epub 2008 Jun 10. Dis Colon Rectum. 2008. PMID: 18543035 Review.

8

Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol.

Leong RW, Gearry RB, Sparrow MP. Leong RW, et al. Among authors: gearry rb. Expert Opin Drug Saf. 2008 Sep;7(5):607-16. doi: 10.1517/14740338.7.5.607. Expert Opin Drug Saf. 2008. PMID: 18759713 Review.

9

Inflammatory bowel disease in New Zealand children--a growing problem.

Gearry RB, Day AS. Gearry RB, et al. N Z Med J. 2008 Oct 3;121(1283):5-8. N Z Med J. 2008. PMID: 18841178 No abstract available.

10

Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.

Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Tarrant KM, et al. Among authors: gearry rb. Am J Gastroenterol. 2008 Dec;103(12):3082-93. doi: 10.1111/j.1572-0241.2008.02212.x. Am J Gastroenterol. 2008. PMID: 19086959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters